Europe Cancer Vaccines Market is expected to grow at a CAGR of 16.29% to reach a market value of USD 1.85 Billion by 2023.
Therapeutic vaccines which are intended to treat an existing cancer by boosting the body’s natural immune response against cancer cells.
(EMAILWIRE.COM, September 28, 2018 ) Overview:
In the year 2018, Europe Cancer Vaccines Market was valued at USD 1.01 Billion. By the year 2023, it is expected to reach USD 1.85 Billion at pace of 16.29% CAGR.
Cancer vaccine is a type of immunotherapy that increases the body's natural defenses by stimulating the immune system to recognize and heal cancer cells. These vaccines are classified into two types, such as prevention and treatment vaccines. Cancer vaccines can be given intravenously in children and adults. These vaccines have many advantages because they can stop the growth of cancer cells, prevent cancer relapse and destroy cancer cells.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/request-sample
Underlying Causes
The growth for Cancer Vaccines Market is driven due to factors like increasing incidence of cancer such as breast cancer, prostate cancer, and lung cancer, rising aging population, increasing consumption of smoking and alcohol, growing awareness about cancer treatments among people, and rising healthcare expenditure. In addition, increasing investments for R&D activities by private organizations, introduction of new vaccines, and technological advancements in cancer treatments are expected to drive market growth. However, high cost and time incurred in development of cancer vaccines, and stringent regulatory policies for approving new vaccines are expected to hinder the growth rate for Europe Cancer Vaccines Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/
Geographic Segmentation:
Based on geography the Europe Cancer Vaccines Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe accounts for second largest revenue share in the Cancer Vaccines Market due to rising prevalence of cancer diseases, and increasing demand for cancer vaccines are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/customize-report
Key Players:
Leading companies for Europe Cancer Vaccines Market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech.
In the year 2018, Europe Cancer Vaccines Market was valued at USD 1.01 Billion. By the year 2023, it is expected to reach USD 1.85 Billion at pace of 16.29% CAGR.
Cancer vaccine is a type of immunotherapy that increases the body's natural defenses by stimulating the immune system to recognize and heal cancer cells. These vaccines are classified into two types, such as prevention and treatment vaccines. Cancer vaccines can be given intravenously in children and adults. These vaccines have many advantages because they can stop the growth of cancer cells, prevent cancer relapse and destroy cancer cells.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/request-sample
Underlying Causes
The growth for Cancer Vaccines Market is driven due to factors like increasing incidence of cancer such as breast cancer, prostate cancer, and lung cancer, rising aging population, increasing consumption of smoking and alcohol, growing awareness about cancer treatments among people, and rising healthcare expenditure. In addition, increasing investments for R&D activities by private organizations, introduction of new vaccines, and technological advancements in cancer treatments are expected to drive market growth. However, high cost and time incurred in development of cancer vaccines, and stringent regulatory policies for approving new vaccines are expected to hinder the growth rate for Europe Cancer Vaccines Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/
Geographic Segmentation:
Based on geography the Europe Cancer Vaccines Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe accounts for second largest revenue share in the Cancer Vaccines Market due to rising prevalence of cancer diseases, and increasing demand for cancer vaccines are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-cancer-vaccines-market-1421/customize-report
Key Players:
Leading companies for Europe Cancer Vaccines Market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results